Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent High Grade Gliomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02698280
What this trial is testing

Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma

Who this might be right for
Glioblastoma
Huashan Hospital 23
Early research (Phase 1)Study completedNCT02444546
What this trial is testing

Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors

Who this might be right for
Childhood AstrocytomaChildhood Atypical Teratoid/Rhabdoid TumorDiffuse Intrinsic Pontine Glioma+7 more
Mayo Clinic 6
Early research (Phase 1)Looking for participantsNCT05698524
What this trial is testing

Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma

Who this might be right for
Recurrent High Grade GliomaAnaplastic AstrocytomaAnaplastic Oligodendroglioma+2 more
University of Nebraska 24
Testing effectiveness (Phase 2)Ended earlyNCT00021229
What this trial is testing

Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 85
Not applicableStudy completedNCT00897611
What this trial is testing

Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant Glioma

Who this might be right for
High Grade Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 42
Not applicableNo Longer AvailableNCT04289155
What this trial is testing

Individual Patient Compassionate Use of GX-I7

Who this might be right for
GlioblastomaHigh Grade GliomaRecurrent Glioblastoma+2 more
Genexine, Inc.
Early research (Phase 1)Study completedNCT00138216
What this trial is testing

Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsUnspecified Childhood Solid Tumor, Protocol Specific
Children's Oncology Group 42
Early research (Phase 1)WithdrawnNCT06463184
What this trial is testing

Study to Assess Xevinapant in Preoperative Subjects With Recurrent High-Grade Glioma (rHGG)

Who this might be right for
Recurrent High-grade Glioma
H. Lee Moffitt Cancer Center and Research Institute
Early research (Phase 1)Study completedNCT01891747
What this trial is testing

A Phase I Study of High-dose L-methylfolate in Combination With Temozolomide and Bevacizumab in Recurrent High Grade Glioma

Who this might be right for
Malignant Glioma
Vanderbilt-Ingram Cancer Center 14
Testing effectiveness (Phase 2)Study completedNCT00064363
What this trial is testing

Talampanel in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Ended earlyNCT01324635
What this trial is testing

Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors

Who this might be right for
Recurrent GliomaHigh-grade MeningiomaBrain Metastasis
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 17
Testing effectiveness (Phase 2)Study completedNCT03234595
What this trial is testing

A Phase I/IIa Study of Cerebraca Wafer Plus Adjuvant Temozolomide (TMZ) in Patients With Recurrent High Grade Glioma

Who this might be right for
Recurrent GBM
Everfront Biotech Co., Ltd. 22
Testing effectiveness (Phase 2)UnknownNCT04588987
What this trial is testing

Neoadjuvant Carilizumab and Apatinib for Recurrent High-Grade Glioma

Who this might be right for
Neoadjuvant TherapyCarilizumabApatinib+1 more
Sun Yat-sen University 60
Early research (Phase 1)Study completedNCT01076530
What this trial is testing

Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Embryonal Tumor+31 more
National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Looking for participantsNCT07424092
What this trial is testing

Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors

Who this might be right for
High Grade GliomaEpendymomaEmbryonal Tumor of Brain+4 more
Clinica Universidad de Navarra, Universidad de Navarra 39
Testing effectiveness (Phase 2)Study completedNCT00004004
What this trial is testing

Procarbazine in Treating Patients With Recurrent Brain Tumor

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Testing effectiveness (Phase 2)Study completedNCT00293423
What this trial is testing

GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma

Who this might be right for
Brain and Central Nervous System Tumors
University of California, San Francisco 96
Testing effectiveness (Phase 2)Study completedNCT00995007
What this trial is testing

Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas

Who this might be right for
Glioblastoma MultiformeGliosarcomaAnaplastic Astrocytoma+2 more
National Cancer Institute (NCI) 112
Very early researchEnded earlyNCT05773326
What this trial is testing

Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG

Who this might be right for
High Grade GliomaGliomaGlioma, Malignant+1 more
Nader Sanai 5
Testing effectiveness (Phase 2)Study completedNCT02490800
What this trial is testing

Phase 1/2a Study of Oral BAL101553 in Adult Patients With Solid Tumors or Glioblastoma or High-grade Glioma

Who this might be right for
Neoplasms
Basilea Pharmaceutica 72
Next Page